Following Andy Burnham's meeting with Arichie Goodburn and the announcement of a national brain cancer lead and accelerated MHRA reviews, Professor of Biomedical innovation at Ulster University and chief scientific officer at CRISM Therapeutics Chris McConville gave his insight regarding the news:
Archie Goodburn has rightly exposed the immense stagnation that brain tumour patients have faced in the UK for over two decades. The commitments made at Downing Street are a necessary response to his campaign.